Skip to main content
Global Bioenergies logo

Global Bioenergies — Investor Relations & Filings

Ticker · ALGBE ISIN · FR0011052257 LEI · 969500H46XRAMTMVB676 PA Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2024-01-18 Board/Management Inform…
Country FR France
Listing PA ALGBE

About Global Bioenergies

https://www.global-bioenergies.com/?lan…

Global Bioenergies develops and commercializes a process to convert renewable resources, such as plant-based sugars and agricultural waste, into isobutene. The company's proprietary technology utilizes fermentation and synthetic biology to produce this key hydrocarbon, which serves as a platform molecule for various applications. The bio-isobutene can be converted into ingredients for the cosmetics industry, specialty chemicals, and renewable fuels. A primary strategic focus is the production of Sustainable Aviation Fuel (SAF) to support the decarbonization of the aviation sector. The process provides a bio-based alternative to petroleum-derived hydrocarbons, aiming to reduce CO2 emissions and dependence on fossil fuels.

Recent filings

Filing Released Lang Actions
Jean-Claude Lumaret, ancien Directeur Général de Carbios, rejoint le Conseil d’Administration de Global Bioenergies
Board/Management Information Classification · 100% confidence The document is a 'COMMUNIQUE DE PRESSE' (Press Release) announcing a change in the company's governance structure: the co-option of a new independent director (Jean-Claude Lumaret) and the resignation of another (Alain Fanet). This directly relates to the composition of the Board of Directors and senior management structure. Based on the provided definitions, the most appropriate category is 'Board/Management Information' (MANG), which covers 'Announcement of changes in the company's board of directors or senior management.' The document is short and is a direct announcement, not a regulatory filing like 10-K or a general regulatory notice (RNS).
2024-01-18 French
Jean-Claude Lumaret, former CEO of Carbios, joins the Board of Directors of Global Bioenergies
Board/Management Information Classification · 100% confidence The document is a press release announcing a change in the company's Board of Directors: the co-option of Jean-Claude Lumaret as an independent director, replacing Alain Fanet. This specific event—the announcement of changes in senior management or the board—directly corresponds to the definition of Board/Management Information (MANG). The document is short and structured as a formal announcement, not a comprehensive report like a 10-K or IR.
2024-01-18 English
Global Bioenergies annonce le début d’une nouvelle phase dans la collaboration avec Shell pour le développement de carburants routiers bas carbone
Regulatory Filings Classification · 95% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a new development contract between Global Bioenergies and Shell regarding low-carbon road fuels. It includes quotes from management and contact information for investors and media. This format is characteristic of an immediate public announcement of a significant business event or partnership update, rather than a comprehensive financial report (like 10-K or IR) or a formal regulatory filing. Since it is an announcement of a business development/collaboration, it fits best under the general 'Regulatory Filings' (RNS) category as a general corporate announcement, or potentially 'Capital/Financing Update' (CAP) if the contract involved significant funding, but RNS is the most appropriate general category for press releases not covered by more specific codes like ER or DIV. Given the short length (under 3000 chars) and the nature of the announcement, RNS is the best fit as a general corporate news release.
2024-01-17 French
Global Bioenergies announces the start of a new phase in its collaboration with Shell to develop low-carbon road fuels
Regulatory Filings Classification · 95% confidence The document is clearly labeled as a "PRESS RELEASE" and announces a new development contract between Global Bioenergies and Shell regarding low-carbon road fuels. It contains quotes from executives and general company information, typical of a corporate announcement intended for immediate public dissemination. It is not a comprehensive financial report (like 10-K or IR), a transcript (CT), or a formal regulatory filing detailing insider trades (DIRS) or shareholder votes (DVA). Since it is a general, timely announcement that doesn't fit the specific categories like ER (Earnings Release) or CAP (Capital/Financing Update), it falls best under the general Regulatory Filings/Announcements category, RNS, as it is a material, non-financial-results-specific update.
2024-01-17 English
Global Bioenergies précise le calendrier du projet de construction de sa nouvelle usine d’isobutène biosourcé pour la cosmétique
Regulatory Filings Classification · 95% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces updates regarding the timeline for constructing a new bio-isobutene plant, including financing details (Bpifrance, France 2030) and future plans for sustainable aviation fuel (SAF). This type of announcement, detailing operational updates, strategic progress, and future project timelines, is typically classified as a general regulatory announcement or press release that doesn't fit the strict definitions of 10-K, ER, or IR. Since it is a formal announcement updating the market on significant operational progress and financing milestones, and it is not a full report, a dividend notice, or a management change, the most appropriate general category is Regulatory Filings (RNS), as it serves as a broad communication to the market about company activities not covered by more specific codes. The document length (3923 chars) is short, suggesting it is an announcement rather than a full report.
2023-12-21 French
Global Bioenergies specifies the schedule of its new biobased isobutene plant for cosmetics
Capital/Financing Update Classification · 95% confidence The document is a 'PRESS RELEASE' dated December 21, 2023, detailing an update on the schedule, technology, and financing for the construction of a new biobased isobutene plant. It discusses future milestones (FEED in summer 2024, construction 2025-2027) and market strategy (cosmetics, SAF). This is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It is an announcement concerning future capital projects and strategic direction, which aligns best with a general corporate update or financing activity announcement. Since it specifically details the progress and financing plan for a major industrial project, it fits well under 'Capital/Financing Update' (CAP) or potentially 'Regulatory Filings' (RNS) if it were a mandatory disclosure. Given the focus on the plant construction schedule and securing financing tranches, CAP is the most specific fit, although it is structured as a press release. However, because it is a general update on strategic progress and financing rather than a formal financial statement or a specific transaction announcement (like M&A or dividend), and it is short (3720 chars), it could also be considered a general regulatory announcement if CAP is too narrow. Reviewing the definitions, 'CAP' covers 'Updates on company fundraising, financing activities, or capital structure changes.' This document explicitly mentions financing tranches and construction timelines, making CAP the strongest fit over the general RNS.
2023-12-21 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.